March 18, 2019
Media Release 18 March 2019 Johannesburg – South African-based international health and wellness business Ascendis Health today reported a 3% increase in revenue to R4 billion for the six months to December 2018 while normalised operating profit was 2% lower at R619 million. International revenue rose by 7% to R2 billion and accounts for 50% […]
ASCENDIS HEALTH SELLS MANUFACTURING PLANT FOR R130 MILLION
December 20, 2018
20 December 2018 Johannesburg – Ascendis Health has concluded a sale agreement of its pharmaceutical manufacturing facility in Isando, Gauteng, to Mylan, one of the world’s leading pharmaceutical companies, for R130 million. The contemplated sale forms part of Ascendis Health’s non-core asset disposal programme announced earlier this year following management’s strategic business review. Chief executive […]
ASCENDIS PROFIT UP 18% ON STRONG INTERNATIONAL GROWTH New strategy to focus on pharma and consumer healthcare sectors
September 25, 2018
ASCENDIS PROFIT UP 18% ON STRONG INTERNATIONAL GROWTH New strategy to focus on pharma and consumer healthcare sectors 25 September 2018 Johannesburg – Ascendis Health, the South African-based international health and wellness company, increased normalised operating profit by 18% to R1.2 billion in the year to June 2018 as revenue grew by 21% to R7.7 […]
Johannesburg – Ascendis Health, the South African-based international healthcare company, today announced the planned disposal of smaller local non-core businesses as part of a strategic business review.
June 25, 2018
MEDIA RELEASE – 25 June 2018 The strategic review, initiated by new CEO Thomas Thomsen on his appointment in March this year, is aimed at creating a sustainable market position for Ascendis, accelerating organic growth, improving cash generation and enhancing profitability. The outcome of the strategic review and the new strategic focus of Ascendis will […]
Ascendis Health is the first healthcare company in South Africa to secure a secondary listing on the A2X Markets (A2X) stock exchange.
May 24, 2018
Ascendis Health CEO Thomas Thomsen said: “Ascendis Health is pleased to complement its primary listing on the JSE with a new and secondary listing on A2X. This will offer investors the option to now trade Ascendis Health shares on either the JSE or A2X.” A2X is a licensed stock exchange which began trading in October […]